KAS
BIO icon

Kestra Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Kestra Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
821
-215
-21% -$61K ﹤0.01% 2963
2026
Q1 		$289K Buy
1,036
+167
+19% +$48.1K ﹤0.01% 2655
2025
Q4 		$263K Buy
869
+20
+2% +$6.24K ﹤0.01% 2647
2025
Q3 		$238K Buy
+849
New +$231K ﹤0.01% 2618
2025
Q2 		– Sell
-854
Closed -$208K – 2832
2025
Q1 		$208K Sell
854
-15
-2% -$4.51K ﹤0.01% 2446
2024
Q4 		$285K Buy
869
+1
+0.1% +$339 ﹤0.01% 2259
2024
Q3 		$290K Sell
868
-106
-11% -$33.7K ﹤0.01% 2116
2024
Q2 		$266K Sell
974
-1,144
-54% -$333K ﹤0.01% 2192
2024
Q1 		$733K Buy
2,118
+1,139
+116% +$375K ﹤0.01% 1429
2023
Q4 		$316K Sell
979
-1,002
-51% -$314K ﹤0.01% 1812
2023
Q3 		$710K Sell
1,981
-6
-0.3% -$2.31K 0.01% 1173
2023
Q2 		$753K Buy
1,987
+107
+6% +$43.5K 0.01% 1109
2023
Q1 		$901K Sell
1,880
-1,151
-38% -$539K 0.01% 992
2022
Q4 		$1.27M Sell
3,031
-705
-19% -$285K 0.01% 944
2022
Q3 		$1.56M Buy
3,736
+1,653
+79% +$824K 0.02% 768
2022
Q2 		$1.03M Buy
2,083
+537
+35% +$280K 0.01% 963
2022
Q1 		$871K Buy
1,546
+97
+7% +$58.5K 0.01% 1024
2021
Q4 		$1.09M Sell
1,449
-916
-39% -$686K 0.01% 939
2021
Q3 		$1.76M Buy
2,365
+1,041
+79% +$780K 0.02% 767
2021
Q2 		$853K Buy
1,324
+129
+11% +$78.5K 0.01% 1017
2021
Q1 		$683K Buy
1,195
+509
+74% +$301K 0.01% 1042
2020
Q4 		$394K Buy
686
+682
+17,050% +$388K ﹤0.01% 1326
2020
Q3 		$337K Buy
+4
New +$2.03K 0.01% 1053

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Kestra Advisory Services's BIO Position: Q2 2026 in Review

Kestra Advisory Services reduced its Bio-Rad Laboratories Class A (BIO) stake by 21% in Q2 2026, selling an estimated $61K and leaving 821 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

Kestra Advisory Services first reported a position in BIO in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.76M in Q3 2021. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Kestra Advisory Services held 821 shares of Bio-Rad Laboratories Class A worth $241K as of Q2 2026.
  • Kestra Advisory Services sold 215 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $61K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2963 holding.
  • Kestra Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's Bio-Rad Laboratories Class A position peaked at $1.76M in Q3 2021.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.